Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Electroacupuncture alleviates TNBS-induced visceral pain and modulates cortical EEG rhythms in association with TREM1/DAP12 pathway inhibition: Enhanced effects with pharmacological TREM1 blockade.

Created on 04 Nov 2026

Authors

Kaixin Wang, Daling Deng, Rui Yu, Tianhao Zhang, Jiwei Shen, Xiaojin Li, Shiwen Fan, Xiangdong Chen

Published in

Molecular pain. Volume 22. Pages 17448069261504906. Epub Nov 03, 2026.

Abstract

BackgroundVisceral pain in inflammatory bowel disease (IBD) lacks effective therapies. Whether the TREM1/DAP12 pathway is associated with electroacupuncture (EA) analgesia and cortical EEG modulation remains unclear.ObjectiveTo determine if spinal TREM1/DAP12 is associated with EA's analgesic and neuromodulatory effects in TNBS-induced visceral pain.MethodsMale Sprague-Dawley rats with TNBS-induced colitis received EA (ST36/ST37), the TREM1 inhibitor Nangibotide, or their combination. Behaviors (PWT, CRD, DAI), spinal TREM1/DAP12, downstream inflammatory mediators, and microglial colocalization were evaluated. Cortical EEG was analyzed using normalized power spectral density (Normalized PSD, %).ResultsEA significantly alleviated visceral/referred hyperalgesia and reduced DAI scores (P < 0.05). TNBS upregulated spinal TREM1, DAP12, TNF-α, NLRP3, and TLR4 and increased TREM1/DAP12 microglial colocalization (P < 0.0001), all reversed by EA (P < 0.001). Nangibotide alone partially mimicked EA's effects, and their combination yielded greater analgesia and molecular suppression (P < 0.05). Normalized EEG analysis revealed that TNBS increased δ power (P < 0.0001) and reduced θ and β power (P < 0.001). Notably, EA and Nangibotide specifically reversed δ elevation and restored θ power (P<0.05) without altering β power (P > 0.05), with greater δ suppression than either treatment alone (P < 0.0001).ConclusionEA alleviates TNBS visceral pain and normalizes cortical δ/θ dysrhythmia, with these effects associated with suppression of microglial TREM1/DAP12 neuroinflammation. Pharmacological TREM1 blockade mimics and enhances EA's effects, supporting this pathway as a promising therapeutic target for visceral pain.

PMID:
42976330
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement